It induces antibodies to block SARS-CoV-2 Spike protein binding to the host receptor ACE2 and produces high titres of virus-neutralizing antibodies and robust cell immune response, thereby completely blocking the virus entry and subsequent infection. This evidence concerns the gene ACE2 and infection.